Avanos Medical (AVNS) 10-Q 2023 Q3 Quarterly report

Exhibit 32(b)

Certification of Chief Financial Officer

Pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code

I, Michael C. Greiner, Chief Financial Officer of Avanos Medical, Inc., certify that, to my knowledge:

(1)the Form 10-Q, filed with the Securities and Exchange Commission on November 1, 2023 (“accompanied report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)the information contained in the accompanied report fairly presents, in all material respects, the financial condition and results of operations ofAvanos Medical, Inc.

Date: November 1, 2023	/s/ Michael C. Greiner
	Michael C. Greiner Senior Vice President, Chief Financial Officer and Chief Transformation Officer (Principal Financial Officer)